Association between the T-786c enos polymorphism and idiopathic osteonecrosis of the head of the femur

被引:37
作者
Glueck, Charles J.
Freiberg, Richard A.
Oghene, Jennifer
Fontaine, Robert N.
Wang, Ping
机构
[1] Jewish Hosp Cincinnati, Ctr Cholesterol, Cincinnati, OH 45229 USA
[2] VA Hosp, Orthoped Surg Serv, Cincinnati, OH 45220 USA
[3] MDL Labs, Cincinnati, OH 45219 USA
关键词
D O I
10.2106/JBJS.F.01421
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Nitric oxide regulates bone turnover by osteoblasts and osteoclasts. Nitric oxide production is impaired by the T-786C eNOS single nucleotide polymorphism, with a substitution of the nucleotide thymine by cytosine at a locus 786 base pairs upstream of the eNOS gene. This leads to vasoconstriction, platelet aggregation, reduced angiogenesis, and reduced bone formation, all of which may be associated with osteonecrosis of the hip. We studied relationships between the T-786C eNOS polymorphism and idiopathic and secondary necrosis of the head of the femur in order to better understand the pathophysiology of osteonecrosis. Methods: With use of polymerase chain reaction methodology, the T-786C eNOS polymorphism was compared in ninety-five patients with femoral head necrosis (including thirty-six nonsmokers with idiopathic necrosis and fifty-nine patients with secondary necrosis) and seventy-two healthy normal adult controls. Results: Homozygosity for the mutant eNOS allele (TT) was present in eight (22%) of thirty-six patients with idiopathic osteonecrosis as compared with one (3%) of thirty-six race, gender, and age-matched controls; heterozygosity (TC) was present in nineteen patients (53%) as compared with ten controls (28%); and the wild-type normal genotype (CC) was present in nine patients (25%) as compared with twenty-five controls (69%) (p = 0.0004). Logistic regression revealed that the T-786C eNOS mutant allele was positively associated with idiopathic osteonecrosis of the femoral head (odds ratio, 6.0; 95% confidence interval, 2.51 to 14.4). The fifty-nine patients with secondary osteonecrosis did not differ from fifty-two race, gender, and age-matched controls in terms of the distribution of the T-786C eNOS polymorphism (p = 0.19) or in terms of mutant allele frequency (30% compared with 21%; p = 0.15). The thirty-six patients with idiopathic osteonecrosis differed from the fifty-nine patients with secondary osteonecrosis in that they were more likely to have mutant eNOS genotypes (p = 0.033) and to have a higher mutant T allele frequency (49% compared with 30%; p = 0.009). Conclusions: The T-786C eNOS polymorphism and resultant reduction of nitric oxide production is associated with, and may contribute to, the pathogenesis of idiopathic osteonecrosis of the femoral head.
引用
收藏
页码:2460 / 2468
页数:9
相关论文
共 56 条
[1]   Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease [J].
Adams, MR ;
McCredie, R ;
Jessup, W ;
Robinson, J ;
Sullivan, D ;
Celermajer, DS .
ATHEROSCLEROSIS, 1997, 129 (02) :261-269
[2]   Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells (vol 9, pg 1370, 2003) [J].
Aicher, A ;
Heeschen, C ;
Mildner-Rihm, C ;
Urbich, C ;
Ihling, C ;
Technau-Ihling, K ;
Zeiher, AM ;
Dimmeler, S .
NATURE MEDICINE, 2004, 10 (09) :999-999
[3]   Reduced endothelial nitric oxide synthase activity and concentration in fetal umbilical veins from maternal cigarette smokers [J].
Andersen, MR ;
Walker, LR ;
Stender, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (01) :346-351
[4]  
Aricò M, 2003, HAEMATOLOGICA, V88, P747
[5]  
Asano Takeshi, 2003, Pharmacogenetics, V13, P675, DOI 10.1097/00008571-200311000-00003
[6]   Legg-Calve-Perthes disease and thrombophilia [J].
Balasa, VV ;
Gruppo, RA ;
Glueck, CJ ;
Wang, P ;
Roy, DR ;
Wall, EJ ;
Mehlman, CT ;
Crawford, AH .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2004, 86A (12) :2642-2647
[7]   The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults [J].
Balasa, VV ;
Gruppo, RA ;
Glueck, CJ ;
Stroop, D ;
Becker, A ;
Pillow, A ;
Wang, P .
THROMBOSIS AND HAEMOSTASIS, 1999, 81 (05) :739-744
[8]   Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation [J].
Barua, RS ;
Ambrose, JA ;
Eales-Reynolds, LJ ;
DeVoe, MC ;
Zervas, JG ;
Saha, DC .
CIRCULATION, 2001, 104 (16) :1905-1910
[9]   Factor V Leiden and prothrombin gene mutation [J].
Björkman, A ;
Svensson, PJ ;
Hillarp, A ;
Burtscher, IM ;
Rünow, A ;
Benoni, G .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (425) :168-172
[10]   The clinical pharmacology of L-arginine [J].
Böger, RH ;
Bode-Böger, SM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :79-99